There are 3161 resources available
1769P - Safety and efficacy with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received no prior anti–colony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study
Presenter: Cesar Serrano
Session: Poster session 06
1771P - Blessed: Expanded yccess for DeltaRex-G in vivo gene therapy for sarcoma, pancreas and breast cancer (NCT04091295) and other solid malignancies (IND# 19130)
Presenter: Sant Chawla
Session: Poster session 06
1772P - Phosphoproteomic biomarker for afatinib response stratification in advanced chordoma
Presenter: Christoph Stange
Session: Poster session 06
1773P - Genomic and transcriptomic analysis of chondrosarcomas to explore new potential treatment options
Presenter: Konstantin Zirov
Session: Poster session 06
1774P - Immunological-molecular profiling of chondrosarcoma (ChS)
Presenter: Piotr Rutkowski
Session: Poster session 06
1775P - Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
Presenter: Evan Rosenbaum
Session: Poster session 06
1776P - Targeting B7H3 biomimetic nanoparticles for strengthening osteosarcoma photodynamic therapy through aggravating DNA damage
Presenter: Tianqi Luo
Session: Poster session 06
1777P - Molecular profiling from next-generation sequencing (NGS) reveals new potential therapeutic targets in patients with pediatric-type sarcomas
Presenter: Anthony Conley
Session: Poster session 06
1778P - Clear cell sarcomas (CCS) express Gp100: A novel immune target for a bispecific T cell engager
Presenter: Elise Nassif Haddad
Session: Poster session 06